Role of cholecystokinin in the intestinal phase of pancreatic circulation in dogs.
The regulatory mechanisms of postprandial pancreatic hyperemia are not well characterized. The aim of this study is to clarify the role of cholecystokinin (CCK) in the intestinal phase of pancreatic circulation. Pancreatic, gastric, and intestinal blood flows were measured by ultrasound transit-time blood flowmeters in five conscious dogs. Pancreatic and gastric secretion and blood pressure were also monitored. Synthetic CCK octapeptide (CCK-8) or gastrin heptadecapeptide (gastrin-17) was infused intravenously, and milk was infused into the duodenum with or without loxiglumide, a specific CCK-A receptor antagonist. CCK-8 induced dose-related increases of pancreatic, but not gastric or intestinal, blood flow and protein secretion without affecting systemic blood pressure. Gastrin-17 did not affect pancreatic blood flow. An intraduodenal infusion of milk increased pancreatic and intestinal blood flows and pancreatic protein secretion. Loxiglumide completely inhibited pancreatic blood flow and protein responses to CCK-8 and milk but not the intestinal blood flow response. CCK is a potent and specific pancreatic vasodilator, with its effect mediated by CCK-A receptors. CCK plays an important role in the regulation of the intestinal phase of the pancreatic circulation in dogs.
Nakajima
M
M
Internal Medicine II, Nagoya University School of Medicine, Nagoya 466-8550, Japan.
Naruse
S
S
Kitagawa
M
M
Ishiguro
H
H
Jin
C
C
Ito
O
O
Hayakawa
T
T
D000818:Animals; D002766:Cholecystokinin / Q000097:blood / Q000378:metabolism / Q000502:physiology*; D004285:Dogs; D005260:Female; D006439:Hemodynamics / Q000502:physiology; D006727:Hormone Antagonists / Q000494:pharmacology; D007422:Intestines / Q000098:blood supply*; D008297:Male; D008892:Milk / Q000502:physiology; D010179:Pancreas / Q000098:blood supply* / Q000378:metabolism; D011377:Proglumide / Q000031:analogs & derivatives* / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors; D012039:Regional Blood Flow / Q000502:physiology
D006727:Hormone Antagonists; D011506:Proteins; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin; C053737:loxiglumide; D002766:Cholecystokinin; D011377:Proglumide